Anti-CLL1 Chimeric Antigen Receptor T Cell Therapy in Children with Relapsed/Refractory Acute Myeloid Leukemia

Scientists tested the safety and efficacy of chimeric antigen receptor T cell therapy in refractory/relapsed acute myeloid leukemia .
[Clinical Cancer Research]
Zhang, H., Wang, P., Li, Z., He, Y., Gan, W., & Jiang, H. (2021). Anti-CLL1 chimeric antigen receptor T cell therapy in children with relapsed/refractory acute myeloid leukemia. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.CCR-20-4543 Cite
Abstract
Bookmark

No account yet? Register

0
Share

Inhibition of STAT3 Prevents Bone Metastatic Progression of Prostate Cancer In Vivo

Effects of signal transducer and activator of transcription 3 (STAT3) inhibitors, Stattic and Napabucasin, on metastatic potential in prostate cancer cells were studied in vitro by assessment of migration capacity, self‐renewal potential, and tumorsphere formation.
[Prostate]
Thulin, M. H., Määttä, J., Linder, A., Sterbova, S., Ohlsson, C., Damber, J.-E., Widmark, A., & Persson, E. (n.d.). Inhibition of STAT3 prevents bone metastatic progression of prostate cancer in vivo. The Prostate, n/a(n/a). https://doi.org/https://doi.org/10.1002/pros.24125 Cite
Full Article
Bookmark

No account yet? Register

0
Share

Hematopoietic Stem Progenitor Cells Lacking HLA Differ from Those Lacking GPI-Anchored Proteins in the Hierarchical Stage and Sensitivity to Immune Attack in Patients with Acquired Aplastic Anemia

To characterize glycosylphosphatidylinositol-anchored protein-deficient and HLA-class I allele-lacking hematopoietic stem progenitor cells in acquired aplastic anemia (AA), researchers studied the peripheral blood of 56 AA patients in remission.
[Leukemia]
Yoroidaka, T., Hosokawa, K., Imi, T., Mizumaki, H., Katagiri, T., Ishiyama, K., Yamazaki, H., Azuma, F., Nanya, Y., Ogawa, S., & Nakao, S. (2021). Hematopoietic stem progenitor cells lacking HLA differ from those lacking GPI-anchored proteins in the hierarchical stage and sensitivity to immune attack in patients with acquired aplastic anemia. Leukemia, 1–11. https://doi.org/10.1038/s41375-021-01202-8 Cite
Abstract
Bookmark

No account yet? Register

0
Share

Rebuilding the Hematopoietic Stem Cell Niche: Recent Developments and Future Prospects

Investigators highlight two areas in the field of HSC research, which just started to unlock the possibilities provided by novel biomaterials, in vitro blood production and studying the pathophysiology of the niche in vitro.
[Acta Biomaterialia]
Chatterjee, C., Schertl, P., Frommer, M., Ludwig-Husemann, A., Mohra, A., Dilger, N., Naolou, T., Meermeyer, S., Bergmann, T. C., Calleja, A. A., & Lee-Thedieck, C. (2021). Rebuilding the hematopoietic stem cell niche: recent developments and future prospects. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2021.03.061 Cite
Full Article
Bookmark

No account yet? Register

0
Share

Azacitidine for Relapse of Acute Myeloid Leukemia or Myelodysplastic Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation, Multicenter PALG Analysis

Researchers conducted retrospective multicenter analysis of patients diagnosed with acute myeloid leukemia or myelodysplastic syndromes who had hematological relapse after allogeneic hematopoietic stem cell transplantation and were treated with azacitidine for this indication.
[European Journal of Haematology]
Drozd‐Sokołowska, J., Karakulska‐Prystupiuk, E., Biecek, P., Kobylińska, K., Piekarska, A., Dutka, M., Waszczuk‐Gajda, A., Mądry, K., Kopińska, A., Gołos, A., Góra‐Tybor, J., Szwedyk, P., Bołkun, Ł., Czyż, A., Giebel, S., Basak, G. W., & Dwilewicz‐Trojaczek, J. (n.d.). Azacitidine for relapse of acute myeloid leukemia or myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation, multicenter PALG analysis. European Journal of Haematology, n/a(n/a). https://doi.org/https://doi.org/10.1111/ejh.13628 Cite
Abstract
Bookmark

No account yet? Register

0
Share

Attrition of X Chromosome Inactivation in Aged Hematopoietic Stem Cells

Researchers demonstrated that LaminA/C defined a distinct repressive nuclear compartment for X chromosome inactivation (XCI) in young HSCs, and its reduction in aged HSCs correlated with an impairment in the overall control of XCI.
[Stem Cell Reports]
Grigoryan, A., Pospiech, J., Krämer, S., Lipka, D., Liehr, T., Geiger, H., Kimura, H., Mulaw, M. A., & Florian, M. C. (2021). Attrition of X Chromosome Inactivation in Aged Hematopoietic Stem Cells. Stem Cell Reports, 0(0). https://doi.org/10.1016/j.stemcr.2021.03.007 Cite
AbstractFull ArticleGraphical Abstract
Bookmark

No account yet? Register

0
Share

Protein S-Nitrosylation Regulates Proteostasis and Viability of Hematopoietic Stem Cell during Regeneration

Investigators found increased nitric oxide during HSC regeneration with an accumulation of protein aggregation.
[Cell Reports]
Yi, W., Zhang, Y., Liu, B., Zhou, Y., Liao, D., Qiao, X., Gao, D., Xie, T., Yao, Q., Zhang, Y., Qiu, Y., Huang, G., Chen, Z., Chen, C., & Ju, Z. (2021). Protein S-nitrosylation regulates proteostasis and viability of hematopoietic stem cell during regeneration. Cell Reports, 34(13). https://doi.org/10.1016/j.celrep.2021.108922 Cite
Full Article
Bookmark

No account yet? Register

0
Share

A Single-Cell Resolution Developmental Atlas of Hematopoietic Stem and Progenitor Cell Expansion in Zebrafish

Using single-cell RNA-sequencing, researchers deciphered a dynamic atlas covering 28,777 cells and nine major cell types of zebrafish caudal hematopoietic tissue.
[Proceedings of the National Academy of Sciences of the United States of America]
Xia, J., Kang, Z., Xue, Y., Ding, Y., Gao, S., Zhang, Y., Lv, P., Wang, X., Ma, D., Wang, L., Han, J.-D. J., & Liu, F. (2021). A single-cell resolution developmental atlas of hematopoietic stem and progenitor cell expansion in zebrafish. Proceedings of the National Academy of Sciences, 118(14). https://doi.org/10.1073/pnas.2015748118 Cite
Full Article
Bookmark

No account yet? Register

0
Share

Reconciling Flux Experiments for Quantitative Modeling of Normal and Malignant Hematopoietic Stem/Progenitor Dynamics

Investigators showed that in vivo flux experiments that came from different laboratories could all be reconciled into a single unifying model, even though they had previously been interpreted as being contradictory.
[Stem Cell Reports]
Takahashi, M., Barile, M., Chapple, R. H., Tseng, Y., Nakada, D., Busch, K., Fanti, A.-K., Säwén, P., Bryder, D., Höfer, T., & Göttgens, B. (2021). Reconciling Flux Experiments for Quantitative Modeling of Normal and Malignant Hematopoietic Stem/Progenitor Dynamics. Stem Cell Reports, 0(0). https://doi.org/10.1016/j.stemcr.2021.02.020 Cite
Full Article
Bookmark

No account yet? Register

0
Share

First Blood: The Endothelial Origins of Hematopoietic Progenitors

Sequential waves of definitive hematopoiesis arise from yolk sac and intembryonic hemogenic endothelia through an endothelial-to-hematopoietic transition.
[Angiogenesis]
Canu, G., & Ruhrberg, C. (2021). First blood: the endothelial origins of hematopoietic progenitors. Angiogenesis. https://doi.org/10.1007/s10456-021-09783-9 Cite
Full Article
Bookmark

No account yet? Register

+1
Share

SETD2 Is Essential for Terminal Differentiation of Erythroblasts during Fetal Erythropoiesis

Loss of Setd2 in hematopoietic cells ablated H3K36me3, and led to anemia with a significant decrease in erythroid cells in the peripheral blood at E18.5.
[Biochemical and Biophysical Research Communications]
Li, Y., Tang, H., Chen, F., Chen, J., Wang, H., Chen, Z., Duan, Y., Wang, X., Li, L., & Ouyang, K. (2021). SETD2 is essential for terminal differentiation of erythroblasts during fetal erythropoiesis. Biochemical and Biophysical Research Communications, 552, 98–105. https://doi.org/10.1016/j.bbrc.2021.03.040 Cite
Abstract
Bookmark

No account yet? Register

0
Share
Share